Norway· NO-ID_BAA85F94-9540-4190-80EC-03F4178C8423
Skopolamin NAF
A scopolamine product containing skopolamin, registered in Norway by Sykehusapoteket Oslo, Rikshospitalet. The same ATC class is registered in 3 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Scopolamine is registered in 3 of 19 countries.
Countries holding a registration under ATC N05CM05 (scopolamine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 2 of them publish a price we can compare per daily dose
Scopolamine · ATC N05CM05
3 / 19 countries
- Canada
- Norwayprice
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Skopolamin
- Manufacturer
- Sykehusapoteket Oslo, Rikshospitalet
- Country
- Norway (NO)
- ATC code
- N05CM05
- ATC class
- Scopolamine
- Defined daily dose
- 0.9 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
- no_merkevare_idID_BAA85F94-9540-4190-80EC-03F4178C8423
- no_varenummer33596810 x 1
- gtin7045283359684
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
335 interactions on record for scopolamine.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Scopolamine · interactions on record
335 records
- 7 severe
- 197 moderate
- 17 minor
- 114 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- DextropropoxypheneN02AC04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Scopolamine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHyoscine 1mg/72hours transdermal patchesImported
- United StatesscopolamineA-S Medication Solutions
- FranceBROMHYDRATE DE SCOPOLAMINE RENAUDIN 0,025 %, solution injectableLABORATOIRE RENAUDIN
- BelgiumBromhydrate de Scopolamine 0,25 mg/mlLaboratoires Sterop
- FinlandOftan-ScopolaminSanten Oy
- CanadaSCOPOLAMINE HYDROBROMIDE INJECTIONOMEGA LABORATORIES LIMITED
- IrelandHyoscine Hydrobromide Martindale Pharma 600 micrograms/ml Solution for InjectionEthypharm
- GermanyBoro-Scopol NOmnivision Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Scopolamine Hbr Sterop
- Germany · Boro-Scopol N, Scopoderm Tts
- Denmark · Scopoderm
- Spain · Escopolamina B. Braun
- Finland · Scopoderm
- France · Bromhydrate De Scopolamine Renaudin, Scopoderm Tts
- United Kingdom (Northern Ireland) · Hyoscine Hydrobromide Wockhardt Uk, Hyoscine Martindale Pharma
- Ireland · Hyoscine Injection Bp Ethypharm, Kwells
- Iceland · Scopoderm
- Luxembourg · Scopoderm Tts
- Malta · Kwells
- Netherlands · Scopoderm
- Sweden · Scopoderm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0b21b07d-33f8-4a81-90ea-02c5ab015da6 GET /v1/drugs/0b21b07d-33f8-4a81-90ea-02c5ab015da6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Skopolamin",
"merkevare_id": "ID_BAA85F94-9540-4190-80EC-03F4178C8423",
"name_form_strength": "Skopolamin NAF inj, oppl 0,3 mg/ml",
"prescription_group": "C"
}See everything about scopolamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.